Almirall

Today, we’re launching the new Almirall corporate website, the heart of our digital ecosystem and a space that brings together our purpose, science, innovation and commitment to patients. From my perspective as an IT Business Partner, digital platforms are how companies express who they are, how they think, and how prepared they are for the future. This new website goes beyond design — it’s a user‑focused, future‑ready platform, built to evolve alongside emerging technologies and new AI‑driven ways of engaging. If you’re curious to see how we’re shaping what comes next, I invite you to take a look 👇 👉 https://www.almirall.com/ #WeAreAlmirall #DigitalTransformation #Innovation #MedicalDermatology

Growth often begins when we step away from routine and broaden our perspective. After a full week at Esade Business School, I leave inspired by the discussions on geopolitics, leadership, strategy, decision-making, AI and many other topics shaping today’s business landscape. Every session challenged us to think beyond and question assumptions. Deeply thankful to Esade , Almirall and my colleagues for such an enriching experience. The journey continues!

Great to have attended the 2026 Gartner Data & Analytics Summit in London over the past few days. As usual, the sessions were extremely insightful and useful, and it was a real pleasure to reconnect and exchange perspectives with so many great colleagues from across this world #Almirall #uncommonbynature

Almirall’s solid Q1 performance reflects the solid foundation we have built across our organisation. Our continued growth in European Dermatology is an important milestone as we further expand our reach and advance our R&D pipeline. Our focus remains to ensure that our expansion is sustainable and aligned with the highest standards as we continue to transform the lives of people living with skin conditions. #WeAreAlmirall

At our Annual General Meeting of Shareholders that was held today in Barcelona, we confirmed Almirall’s strong trajectory toward sustained growth and margin expansion for 2026. We are delivering consistent growth driven by the strong performance of our European dermatology business, reinforcing our position and relevance with both patients and the dermatology community. Our sustained growth enables our robust investment in innovation, and our R&D pipeline is a key driver of our future leadership in dermatology. We remain focused on financial excellence to support our ambition of becoming a global leader in medical dermatology! #WeAreAlmirall #AGM

I’ve learned that in early R&D, the most expensive mistakes are usually simple: running the wrong experiments, or telling the wrong story from the right data. After a decade in R&D, including the last five years bringing biologics into Almirall ’s R&D, I’m now working independently through Forward R&D Consulting , partnering with research teams and investors on hands‑on scientific questions across immunology, dermatology, and oncology, particularly when time or internal expertise is limited.

Last week, I had the opportunity to spend time with the #Almirall Iberia team. I truly value these moments, as they allow me to stay close to the work that is happening where we make tangible impact to patients, the medical community, and society - in the countries where we operate. Every interaction with our teams is a tremendous learning experience for me and I am proud of the contributions I am able to witness. And these internal meetings remind me of how our shared ambition translates into real impact by everyone contributing and achieving together what goes beyond each individual role. The Almirall Iberia team are a great example of this: you bring to life our purpose in the actions you take every day; your passion and enthusiasm drive excellence in execution, and you demonstrate the attitude we need to achieve your goals. Thank you very much for your passion, dedication, and strive to make a difference to patients and the medical community. #AlmirallImparables2026 #WeAreAlmirall